FDA Largely Ignored At Appropriations Subcommittee Mark-Up
This article was originally published in The Pink Sheet Daily
Executive Summary
Rep. DeLauro proposes only amendment, which did not affect FDA and was defeated, but also warns FDA cuts could endanger Americans’ health.
You may also be interested in...
FDA Spending Bill Goes To House Panel At Lower Level Than Senate
A House appropriations subcommittee on June 6 will mark up a bill that would give FDA $44 million less to spend in Fiscal 2013 than a measure produced by the Senate Appropriations Committee, indicating a conference committee will be the final arbiter of agency funding.
DTC User Fees Rejected By House Approps Panel As FDA Safety Funds Get Boost
The House Appropriations Committee opted for using federal money, rather than fees from industry, to finance speedier FDA review of direct-to-consumer television ads when it approved a $1.7 billion fiscal year 2008 funding package for the agency July 19
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.